- 22/11/2002 - Colorectal cancer trial commenced and Virion project (HIV) update
- 16/10/2002 - Appendix 4 C - Quarterly report 30 September 2002
- 11/10/2002 - Financial Report for the year ended 30 June 2002
- 10/10/2002 - ASX Announcement, Biotron successful in grant applications
- 01/10/2002 - Notice of Annual General Meeting (Cover letter) ; Full notice
- 13/9/2002 - Preliminary final report for the year ending 30th of June 2002
- 28/8/2002 - Letter to ASX, Re:Independent Tests verify the company's HIV compound to be effective and non-toxic
- 28/6/2002 - Granting of options
- 28/6/2002 - Exercising of options
- 25/6/2002 - Appointment of a director
- 31/5/2002 - Prostate Cancer Trial Commenced
- 24/5/2002 - Company compound shown to inhibit HIV-1 replication
- 11/4/2002 - Appendix 4 C - Quarterly Report 31 March 2002
- 25/1/2002 - Appendix 4 C - Quarterly Report 30 Dec 2001
